Perspective Therapeutics Files 8-K

Ticker: CATX · Form: 8-K · Filed: Nov 6, 2025 · CIK: 728387

Sentiment: neutral

Topics: 8-K, corporate-filing, pharmaceuticals

TL;DR

Perspective Therapeutics filed an 8-K on Nov 6, 2025. Check it for financial updates.

AI Summary

Perspective Therapeutics, Inc. filed an 8-K on November 6, 2025, reporting on other events and financial statements. The company, formerly known as Isoray, Inc., is incorporated in Delaware and headquartered in Seattle, Washington.

Why It Matters

This filing provides an update on the company's corporate events and financial status, which is important for investors to monitor.

Risk Assessment

Risk Level: low — This is a routine filing with no immediate indication of significant risk or opportunity.

Key Numbers

Key Players & Entities

FAQ

What specific 'Other Events' are being reported in this 8-K filing?

The filing indicates 'Other Events' as an item information, but the specific details of these events are not provided in the excerpt.

What is the significance of the former company names listed?

The former names, Isoray, Inc., IsoRay, Inc., and CENTURY PARK PICTURES CORP, indicate historical corporate changes and name evolutions for Perspective Therapeutics, Inc.

When was the company incorporated and what is its fiscal year end?

The company was incorporated in Delaware and its fiscal year ends on December 31st.

What is the primary business of Perspective Therapeutics, Inc. according to its SIC code?

According to its Standard Industrial Classification (SIC) code 2834, the company is involved in Pharmaceutical Preparations.

What is the filing date and the earliest event date reported?

The filing date and the date of the earliest event reported are both November 06, 2025.

Filing Stats: 413 words · 2 min read · ~1 pages · Grade level 10.6 · Accepted 2025-11-06 08:00:40

Key Financial Figures

Filing Documents

01 Other Events

Item 8.01 Other Events. On November 6, 2025, Perspective Therapeutics, Inc. updated its corporate presentation. A copy of the presentation is filed as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated by reference into this Item 8.01.

01 Financial Statements and Exhibits

Item 9.01 Financial Statements and Exhibits. (d) Exhibits Exhibit No. Description 99.1 Corporate Presentation . 104 Cover Page Interactive Data File (embedded within the Inline XBRL document).

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. PERSPECTIVE THERAPEUTICS, INC. Date: November 6, 2025 By: /s/ Joel Sendek Joel Sendek Chief Financial Officer

View Full Filing

View this 8-K filing on SEC EDGAR

View on Read The Filing